ArticleGeriatrics (Basel, Switzerland)2018
Using the A/T/N Framework to Examine Driving in Preclinical AD.
Article in Geriatrics (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02414347 (F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A), which is not on this map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
F 18 T807 Tau PET Imaging of Alzheimer's Disease [IND# 123119] Protocol A
Who cites it
6 citing papers in PubMed.
- Associations between Aβ40, Aβ42, and tau and postoperative delirium in older adults undergoing cardiac surgery.Journal of neurology · 2025Article
- Everyday Driving and Plasma Biomarkers in Alzheimer's Disease: Leveraging Artificial Intelligence to Expand Our Diagnostic Toolkit.Journal of Alzheimer's disease : JAD · 2023Article
- ATN profile classification across two independent prospective cohorts.Frontiers in medicine · 2023Article
- Improving Our Understanding of Driving Changes in Preclinical and Early Symptomatic Alzheimer's Disease: The Role of Naturalistic Driving Studies.Journal of Alzheimer's disease reports · 2022Review
- Cerebro-spinal fluid biomarker levels: phosphorylated tau (T) and total tau (N) as markers for rate of progression in Alzheimer's disease.BMC neurology · 2020Observational
- The AT(N) framework for Alzheimer's disease in adults with Down syndrome.Alzheimer's & dementia (Amsterdam, Netherlands) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.